載入...
Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2
We here describe the development and validation of IMMUNO-COV™, a high-throughput clinical test to quantitatively measure SARS-CoV-2-neutralizing antibodies, the specific subset of anti-SARS-CoV-2 antibodies that block viral infection. The test measures the capacity of serum or purified antibodies t...
Na minha lista:
| 發表在: | bioRxiv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Cold Spring Harbor Laboratory
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7302210/ https://ncbi.nlm.nih.gov/pubmed/32577655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.05.26.117549 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|